RE-A VIRAL VIDEO OF BULLYING OF A FEMALE STUDENT IN BOUESTI. (PHOTOS). #PRESS RELEASE.

Image
 BAMIDELE OLUMILUA UNIVERSITY OF EDUCATION, SCIENCE AND TECHNLOGY, IKERE-EKITI RE-A VIRAL VIDEO OF BULLYING OF A FEMALE STUDENT IN BOUESTI It has come to our attention that a disturbing incident involving some  students of the Bamidele Olumilua University of Education, Science and Technology, Ikere-Ekiti (BOUESTI) has surfaced on social media platforms. A video showing one Miss Opemiposi Precious BOLAJI, an 18 year old 100L Mass Communication student beating her colleague identified as Miss Gloria AJAYI, a 100L Mass Communication student, in a private hostel outside the University campus has gone viral. In accordance with our institution's policies and extant regulations, the students who were captured in the viral video, appeared  before the Students' Disciplinary Committee at its emergency meeting held on Monday, May 6, 2024 for interrogations and appropriate recommendations, the report of which has been submitted to the University authorities. The University authorities  con

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

ACTOR BABA IJESHA APPEALS FIVE-YEAR JAIL SENTENCE FOR SEXUAL ASSAULT. (PHOTO).

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

PUNISH MY ABUSERS WITHIN 48 HOURS OR FACE LAWSUIT- STUDENT BULLIED BY HER CLASSMATES THREATEN SCHOOL AUTHORITIES. (PHOTO).